Efficacy and safety of integrated Chinese and Western medicine in advanced pancreatic cancer: A double-center retrospective cohort study

Key Points

• Integrated Chinese and Western medicine notably improved long-term efficacy for advanced pancreatic cancer patients.
• Patients demonstrated significant reductions in serum tumor markers and enhanced immune function.
• Retrospective cohort analysis across two centers provided comprehensive data supporting treatment benefits.
• The findings highlight the need for further studies to confirm these results in larger, diverse populations.